Form Type:  D
Filing Date:  5/19/2017 
CIK:  0001603454 
Address:  16305 36TH AVENUE N
City, State, Zip:  MINNEAPOLIS, Minnesota 55446 
Telephone:  763-392-0767 
Last Trade
Last Trade: 
0.04 (0.21%)  
Trade Time: 
Apr 26  
Market Cap: 
Trade CELC now with 

© 2018  
Description of Business
Unless otherwise provided in this Annual Report on Form 10-K, references to the "Company," "we," "us," and "our" and similar references refer to Celcuity Inc., a Delaware corporation. We are a cellular analysis company that is discovering new cancer sub-types and commercializing diagnostic tests designed to significantly improve the clinical outcomes of cancer patients treated with targeted therapies. Our proprietary CELx diagnostic platform is the only commercially ready technology we are aware of that uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the targeted therapy that best treats it. We believe our CELx platform provides two important improvements over traditional molecular diagnostics. First, molecular diagnostics can only provide a snapshot of the genetic mutations present in a patient's tumor because they analyze dead cells.
Register and access this filing in: